Acadia Pharmaceuticals reported $2.95M in Cost of Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Acadia Pharmaceuticals ACAD:US $ 2.95M 0.39M
ALKERMES ALKS:US 55.16M 1.48M
Alnylam Pharmaceuticals ALNY:US $ 35.63M 2.04M
Biogen BIIB:US $ 753.9M 93.8M
Biomarin Pharmaceutical BMRN:US $ 116.96M 2.78M
Bristol Myers Squibb BMY:US $ 2471M 115M
Corcept Therapeutics CORT:US $ 1.25M 0.1M
Eisai 4523:JP Y 50738M 6516M
Eli Lilly And LLY:US $ 2072.1M 21.9M
Intercept Pharmaceuticals ICPT:US $ 0.76M 0.26M
Intra Cellular Therapies ITCI:US $ 3.16M 0.62M
Johnson & Johnson JNJ:US $ 7598M 357M
Moderna Inc MRNA:US 1.02B 65M
Neurocrine Biosciences NBIX:US $ 4.6M 0.5M
Pfizer PFE:US $ 10010M 399M
Ptc Therapeutics PTCT:US $ 10.14M 0.81M
Sarepta Therapeutics SRPT:US $ 31.44M 0.3M
Seattle Genetics SGEN:US $ 87.63M 0.94M
Ultragenyx Pharmaceutical RARE:US $ 6.1M 2.59M
Vanda Pharmaceuticals VNDA:US $ 5.66M 0.57M
Vertex Pharmaceuticals VRTX:US $ 245.8M 1.59M
YTE INCY:US $ 37.21M 1.36M